Omeros Corporation
NASDAQOmeros Corporation heads into its May 14 earnings report with the lending market for its shares as tight as it has ever been — a setup that makes the short side of this stock unusually constrained. The borrow squeeze is the dominant story heading into the print. Availability has collapsed to zero — every share in the lending pool is currently lent out — matching the tightest…
Snapshot as of 14 May 2026
Omeros Corporation heads into its May 14 earnings report with the lending market for its shares as tight as it has ever been — a setup that makes the short side of this stock unusually constrained. The borrow squeeze…
Omeros Corporation enters its Q1 2026 earnings release — due after the close on May 14 — in a state of genuine short-selling pressure, with one of the tightest borrow markets in the small-cap pharma space and a short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OMER — free to start on ORTEX.
Sign up for free →Open OMER on ORTEX